Decreasing prevalence of tophaceous gout.
Retrospective analysis of newly diagnosed gout cases seen at the Mayo Clinic from 1949 through 1972 shows a progressive decline in tophaceous gout, from 14% to 3%. Gout diagnoses remained stable in a range of 1.5 to 2.2/1,000 patients seen.
D003078:Colchicine / Q000627:therapeutic use; D006073:Gout / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D008910:Minnesota; D011339:Probenecid / Q000627:therapeutic use; D012189:Retrospective Studies; D013442:Sulfinpyrazone / Q000627:therapeutic use
D011339:Probenecid; D003078:Colchicine; D013442:Sulfinpyrazone